Low-dose recombinant leukocyte interferon-alpha treatment of hepatitis C viral infection in renal transplant recipients. A pilot study.
Therret
E
E
Service de Transplantation, de Néphrologie Pédiatrique, et d'Hépatologie, Hôpital Necker, Paris, France.
Pol
S
S
Legendre
C
C
Gagnadoux
M F
MF
Cavalcanti
R
R
Kreis
H
H
D000328:Adult; D000410:Alanine Transaminase / Q000378:metabolism; D001219:Aspartate Aminotransferases / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D005260:Female; D005500:Follow-Up Studies; D006526:Hepatitis C / Q000150:complications / Q000188:drug therapy* / Q000201:enzymology; D006801:Humans; D007370:Interferon Type I / Q000009:adverse effects / Q000627:therapeutic use*; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D011994:Recombinant Proteins; D005723:gamma-Glutamyltransferase / Q000378:metabolism
D007370:Interferon Type I; D011994:Recombinant Proteins; D005723:gamma-Glutamyltransferase; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase